References
- Kennedy RH, Danielson MA, Mulder DW, et al. Guillain-Barré syndrome: a 42-year epidemiologic and clinical study. Mayo Clin Proc 1978: 53(2): 93–9
- Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine (Baltimore) 1969: 48(3): 173–215
- Koski CL, Gratz E, Sutherland J, et al. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome. Ann Neurol 1986: 19(6): 573–7
- Lundkvist I, van Doom PA, Venmeulen M, et al. Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeutic. Immunol Rev 1989: 110: 105–17
- Horowitz SH. The idiopathic polyradiculoneuropathies: a historical guide to an understanding of the clinical syndromes. Acta Neurol Scand 1989: 80(5): 369–86
- Kinnunen E, Farkkila M, Hovi T, et al. Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign. Neurology 1989: 39(8): 1034–6
- Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. BMJ (Clin Res) 1984: 288(6434): 1867–70
- Singh NK, Jaiswal AK, Misra S, et al. Assessment of autonomic dysfunction in Guillain-Barré syndrome and its prognostic implications. Acta Neurol Scand 1987: 75(2): 101–5
- Dalos NP, Borel C, Hanley DF. Cardiovascular autonomic dysfunction in Guillain-Barré syndrome: therapeutic implications of Swan-Ganz monitoring. Arch Neurol 1988: 45(1): 115–7
- Vincken WG, Elleker MG, Cosio MG. Flow-volume loop changes reflecting respiratory muscle weakness in chronic neuromuscular disorders. Am J Med 1987: 83(4): 673–80
- Adams RD, Victor M. Principles of neurology. New York: McGraw-Hill, 1989: 1035–9
- The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985: 35(8): 1096–104
- Loffel NB, Rossi LN, Mumenthaler M, et al. The Landry-Guillain-Barré syndrome: complications, prognosis and natural history in 123 cases. J Neurol Sci 1977: 33(1–2): 71–9
- Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988: 51(5): 605–12
- Miller RG, Peterson GW, Daube JR, et al. Prognostic value of electrodiagnosis in Guillain-Barré syndrome. Muscle Nerve 1988: 11(7): 769–74
- Cornblath DR, Mellits ED, Griffin JW, et al. Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol 1988: 23(4): 354–9
- Donofrio PD, Wilbourn AJ, Albers JW, et al. Acute arsenic intoxication presenting as Guillain-Barré-like syndrome. Muscle Nerve 1987: 10(2): 114–20
- Asbury AK. Diseases oi the peripheral nervous system. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's principles of internal medicine. 11th ed. New York: McGraw-Hill, 1987: 2063
- Miller RG, Storey JR, Greco CM. Ganciclovir in the treatment of progressive AIDS-related poly-radiculopathy. Neurology 1990: 40(4): 569–74
- Wuest D, Goldfinger D. Plasmapheresis in the treatment of acute relapsing inflammatory demyelinating polyradiculoneuropathy associated with human immunodeficiency virus infection: a case report. J Clin Apheresis 1988: 4(4): 149–51
- Scaff M, Rabello GD, Marchiori PE. [Acute polyradiculoneuritis and acquired immunodeficiency virus.] Arq Neuropsiquiatr 1989: 47(1): 114–7 (Por)
- Hughes RA, Newsom-Davis JM, Perkin GD, et al. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978: 2(8093): 750–3
- Dyck PJ, Kurtzke JF. Plasmapheresis in Guillain-Barré syndrome. (Editorial) Neurology 1985: 35(8): 1105–7
- Reddi A, Frank O, DeAngelis B, et al. Vitamin status in patients undergoing single or multiple plasmapheresis. J Am Coll Nutr 1987: 6(6): 485–9
- Kleyweg RP, van der Meche FG, Meulstee J. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin. Neurology 1988: 38(10): 1639–41